Zobrazeno 1 - 10
of 49
pro vyhledávání: '"E, Ranklev Twetman"'
Autor:
Mikael Bodelsson, H. Rüffert, Clemens R. Müller, A. Gehrig, E. Ranklev-Twetman, Gunilla Islander, Marcus Broman
Publikováno v:
British Journal of Anaesthesia. 102:642-649
BACKGROUND: Malignant hyperthermia (MH), linked to the ryanodine receptor 1 gene (RYR1) on chromosome 19, is a potentially lethal pharmacogenetic disorder which may lead to a disturbance of intracellular calcium homeostasis when susceptible individua
Publikováno v:
Clinical Genetics. 50:455-458
Malignant hyperthermia (MH) susceptibility is considered a subclinical myopathy or a pharmacogenetic trait, and is believed to be closely associated with central core disease (CCD). Data support the notion that MH susceptibility is heterogeneous, wit
Publikováno v:
Acta Anaesthesiologica Scandinavica. 46:1144-1149
Background: The in vitro contracture test (IVCT) is the golden standard to diagnose malignant hyperthermia susceptibility (MHS). A high reproducibility is important for a high validity of a test. Methods: We have therefore analyzed IVCT in 838 patien
Autor:
F. R. Ellis, H. Kress, H. Ørding, M. Snoeck, S. Cozzolino, W. Mortier, R. Krtvosic‐Horber, James J. A. Heffron, Paul Stieglitz, V. Brancadoro, L. Heytens, Y Nivoche, Albert Urwyler, E. Ranklev‐Twetman, Frank Wappler, Vincenzo Tegazzin, S. Sigurdsson, Frank Lehmann-Horn, P. J. Halsall, G. Kozak‐Ribbens, E. Hartung, V. Glauber, E. F. Gonano
Publikováno v:
Acta Anaesthesiologica Scandinavica. 41:955-966
Background: Determination of sensitivity and specificity of the in vitro contracture test (IVCT) for malignant hyperthermia (MH) susceptibility using the European MH Group (EMHG) protocol has been performed in some laboratories but only on a small sa
Autor:
E. Ranklev Twetman, Gunilla Islander
Publikováno v:
Acta Anaesthesiologica Scandinavica. 41:731-735
Background:Malignant hyperthermia susceptibility is a pharmacogenetic disorder in which susceptible individuals may develop a potentially life-threatening hypermetabolism when exposed to certain anaesthetic agents. The most common diagnostic method i
Autor:
G. Islander, E. Ranklev‐Twetman
Publikováno v:
Acta Anaesthesiologica Scandinavica. 39:819-821
In vitro contracture test is still the most reliable method for diagnosing malignant hyperthermia susceptibility. In order to investigate the reliability of Malignant Hyperthermia Negative (MHN) results, a questionnaire was sent to 237 persons of who
Publikováno v:
Acta Anaesthesiologica Scandinavica; 46(9), pp 1144-1149 (2002)
BACKGROUND: The in vitro contracture test (IVCT) is the golden standard to diagnose malignant hyperthermia susceptibility (MHS). A high reproducibility is important for a high validity of a test. METHODS: We have therefore analyzed IVCT in 838 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d67455db297aa1a70b67652cac4414d6
https://lup.lub.lu.se/record/110753
https://lup.lub.lu.se/record/110753
Autor:
H, Ording, V, Brancadoro, S, Cozzolino, F R, Ellis, V, Glauber, E F, Gonano, P J, Halsall, E, Hartung, J J, Heffron, L, Heytens, G, Kozak-Ribbens, H, Kress, R, Krivosic-Horber, F, Lehmann-Horn, W, Mortier, Y, Nivoche, E, Ranklev-Twetman, S, Sigurdsson, M, Snoeck, P, Stieglitz, V, Tegazzin, A, Urwyler, F, Wappler
Publikováno v:
Acta anaesthesiologica Scandinavica. 41(8)
Determination of sensitivity and specificity of the in vitro contracture test (IVCT) for malignant hyperthermia (MH) susceptibility using the European MH Group (EMHG) protocol has been performed in some laboratories but only on a small sample from th
Publikováno v:
Acta anaesthesiologica Scandinavica. 40(5)
Background: Malignant Hyperthermia (MH) is regarded as a dominantly inherited condition. Therefore, most investigators do not test the second parent if the first parent is found to be MH susceptible (MHS). The purpose of this study was to validate th
Publikováno v:
Lakartidningen. 89(21)